Tag Archives: NHRI’s Antibody Therapy for the Novel COVID-19 Virus Reveals Promise in Animal Tests

NHRI’s Antibody Therapy for the Novel COVID-19 Virus Reveals Promise in Animal Tests

The advancement in informatics and diagnostic technologies have added to the growth of the biotech and gene editing vertical. With the most recent advancements in metabolomics analytical technologies and fields comprising monoclonal antibodies reveal the precise value of metabolomics tools in gene-function analysis, diagnostic platforms, biomarker discovery, and systems biology. Since metabolites characterize the downstream […]